Synthetic biology confronts publics and policy makers: Challenges for communication, regulation and commercialization

Tania Bubela, Gregory Hagen, Edna Einsiedel

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)

Abstract

The novelty of synthetic biology lies in the use of synthesized parts that can be arranged to make useful products. Such advanced, high-throughput genetic engineering projects redesign and fabricate existing biological systems as well as new biological parts, devices and systems that do not occur in nature. This Opinion discusses challenges raised by synthetic biology for public acceptance, regulation, commercialization and the emerging global issue of access to genetic resources and information. As with all new fields of research, maintaining the trust of the public and policy regulators is paramount. Hype and exaggerated claims are counterproductive to developing adaptive and ethically sound regulatory models responsive to stakeholder concerns.

Original languageEnglish
Pages (from-to)132-137
Number of pages6
JournalTrends in Biotechnology
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synthetic biology confronts publics and policy makers: Challenges for communication, regulation and commercialization'. Together they form a unique fingerprint.

Cite this